Y-mAbs Therapeutics
YMAB
$15.50
Share price
5.37%
Change (1 day)
151.22%
Change (1 year)
Categories
Y-mAbs Therapeutics (YMAB) - Cash on Hand
Cash on Hand as of December 2023 : $78.63 M
According to Y-mAbs Therapeutics
's latest financial reports the company has $78.63 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Y-mAbs Therapeutics - Cash on Hand chart (from 2017 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $78.63 M | -25.65% |
| 2022-12-31 | $0.10 B | -41.75% |
| 2021-12-31 | $0.18 B | 58.39% |
| 2020-12-31 | $0.11 B | -44.66% |
| 2019-12-31 | $0.20 B | 40.11% |
| 2018-12-31 | $0.14 B | 63.39% |
| 2017-12-31 | $90.48 M | 436.2% |
| 2016-12-31 | $16.87 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 164.74% | 🇺🇸 USA |